KRAS, NRAS, and BRAF Mutation Pattern in Metastatic Colorectal Cancer: A Study from Northwest Iran

KRAS, NRAS, and BRAF Mutation Pattern in Metastatic Colorectal Cancer: A Study from Northwest Iran

Introduction: Colorectal cancer is currently the third most common cancer in terms of incidence and mortality in Iran. Different gene mutations may confer different degrees of biological aggressiveness and reduce the effectiveness of targeted therapeutic strategies in metastatic Colorectal Cancer (m...

Full description

Bibliographic Details
Main Authors:	Roya Dolatkhah, Saeed Dastgiri, Iraj Asvadi Kermani, Jamal Eivazi Ziaei, Alireza Nikanfar, Zohreh Sanaat, Amir Taher Eftekhar Sadat, Mohammad Hossein Somi
Format:	Article
Language:	English
Published:	JCDR Research and Publications Private Limited 2019-08-01
Series:	Journal of Clinical and Diagnostic Research
Subjects:	colorectal neoplasm metastasis oncogene
Online Access:	https://jcdr.net/articles/PDF/13068/41920_CE[Ra1]_F(SL)_PF1(AJ_SHU)_PFA(AJ_SHU)_PN(SL).pdf

Similar Items

Impact of RAS/RAF mutations on clinical and prognostic outcomes in metastatic colorectal cancer
by: Roya Dolatkhah, et al.
Published: (2021-01-01)

Utilization evaluation of factor concentration and frequencyof bleeds among patients with haemophilia "A" and haemophilia "B" in northwest Iran
by: Roya Dolatkhah, et al.
Published: (2013-12-01)

Delayed hemolytic transfusion reaction with multiple alloantibody (Anti S, N, K) and a monospecific autoanti-JK b in intermediate β-thalassemia patient in Tabriz
by: Roya Dolatkhah, et al.
Published: (2013-01-01)

KRAS/NRAS/BRAF Mutations as Potential Targets in Multiple Myeloma
by: Sergiu Pasca, et al.
Published: (2019-10-01)

KRAS and NRAS Translation Is Increased upon MEK Inhibitors-Induced Processing Bodies Dissolution
by: Olivia Vidal-Cruchez, et al.
Published: (2023-06-01)

Molecular Pattern and Clinical Implications of KRAS/NRAS and BRAF Mutations in Colorectal Cancer
by: İvo Gökmen, et al.
Published: (2023-09-01)

Epidemiological aspects of colorectal cancer in East Azerbaijan, Northwest Iran: five year survival analysis
by: Ramin Barnous, et al.
Published: (2021-08-01)

High prevalence of unusual KRAS, NRAS, and BRAF mutations in POLE‐hypermutated colorectal cancers
by: Loetitia Favre, et al.
Published: (2022-09-01)

Seroprevalence of Cytomegalovirus in blood donors in the northwest of Iran
by: Jamal Eivazi-Ziaei, et al.
Published: (2013-12-01)

Mutation Status and Immunohistochemical Correlation of KRAS, NRAS, and BRAF in 260 Chinese Colorectal and Gastric Cancers
by: Qiwei Yang, et al.
Published: (2018-10-01)

Correlation between KRAS, NRAS and BRAF mutations and tumor localizations in patients with primary and metastatic colorectal cancer
by: Aleksandra Bożyk, et al.
Published: (2021-03-01)

KRAS, NRAS, BRAF, HER2 and microsatellite instability in metastatic colorectal cancer – practical implications for the clinician
by: Afrăsânie Vlad-Adrian, et al.
Published: (2019-09-01)

Association of Clinicopathological Profile and Immunohistochemical Expression of KRAS and BRAF in Colorectal Carcinoma: A Cross-sectional Study
by: Mandira Mitra, et al.
Published: (2023-09-01)

Efficacy of first‐line immune checkpoint inhibitors in patients with advanced NSCLC with KRAS, MET, FGFR, RET, BRAF, and HER2 alterations
by: Yuji Uehara, et al.
Published: (2022-06-01)

Comparison of bone mineral density in young patients with breast cancer and healthy women
by: Sousan Kolahi, et al.
Published: (2014-05-01)

BRAF mutation in colorectal cancer: An update
by: Colombo Alfredo, et al.
Published: (2023-01-01)

Evaluation of KRAS, NRAS and BRAF mutations detection in plasma using an automated system for patients with metastatic colorectal cancer.
by: Claire Franczak, et al.
Published: (2020-01-01)

Frequency of NRAS Gene Mutation in Wild Type KRAS and BRAF Colorectal Cancers; a Single Center Study
by: Hooria Momenzadeh, et al.
Published: (2018-01-01)

Oncogenic BRAF-Mediated Melanoma Cell Invasion
by: Hezhe Lu, et al.
Published: (2016-05-01)

Tumors carrying BRAF-mutations over-express NAMPT that is genetically amplified and possesses oncogenic properties
by: Valentina Audrito, et al.
Published: (2022-03-01)

Incidence of Leukemia in the Northwest of Iran
by: Atabak Asvadi Kermani, et al.
Published: (2011-07-01)

Barriers to breast cancer screening in Iranian females: a review article
by: Nazanin Masoudi, et al.
Published: (2022-01-01)

<i>KRAS, NRAS, BRAF, HER2</i> and MSI Status in a Large Consecutive Series of Colorectal Carcinomas
by: Aleksandr S. Martianov, et al.
Published: (2023-03-01)

INFLUENCE OF SOMATIC MUTATIONS OF KRAS, NRAS, BRAF AND MICROSATELLITE INSTABILITY STATUS ON SURVIVAL OF COLORECTAL CANCER PATIENTS WITH PERITONAL CARCINO
by: V. P. Shubin, et al.
Published: (2020-10-01)

Prevalence of oral human papilloma virus in healthy individuals in East azerbaijan province of iran.
by: Sharareh Seifi, et al.
Published: (2013-01-01)

Prevalence of Oral Human Papilloma Virus in Healthy Individuals in East Azerbaijan Province of Iran
by: Sharareh Seifi, et al.
Published: (2013-01-01)

STAT3 Relays a Differential Response to Melanoma-Associated <i>NRAS</i> Mutations
by: James Kim, et al.
Published: (2020-01-01)

Two multiplex assays that simultaneously identify 22 possible mutation sites in the KRAS, BRAF, NRAS and PIK3CA genes.
by: Irene Lurkin, et al.
Published: (2010-01-01)

Accurate detection of KRAS, NRAS and BRAF mutations in metastatic colorectal cancers by bridged nucleic acid-clamp real-time PCR
by: Yuki Nagakubo, et al.
Published: (2019-11-01)

Epidemiologic profile of breast cancer in Iran: A systematic review and meta-analysis
by: Zohreh Sanaat, et al.
Published: (2024-03-01)

Cytotoxicity of SRJ23 and its derivatives, expression and SRJ23 binding of KRas G12V oncoprotein
by: Tan, Michelle Siying
Published: (2017)

Effects of NRAS Mutations on Leukemogenesis and Targeting of Children With Acute Lymphoblastic Leukemia
by: Jiabi Qian, et al.
Published: (2022-02-01)

Targeting Oncogenic BRAF: Past, Present, and Future
by: Aubhishek Zaman, et al.
Published: (2019-08-01)

KRAS/NRAS Mutations Associated with Distant Metastasis and BRAF/PIK3CA Mutations Associated with Poor Tumor Differentiation in Colorectal Cancer
by: Zeng J, et al.
Published: (2023-09-01)

Evidence that synthetic lethality underlies the mutual exclusivity of oncogenic KRAS and EGFR mutations in lung adenocarcinoma
by: Arun M Unni, et al.
Published: (2015-06-01)

Combination therapy of BRAF inhibitors for advanced melanoma with BRAF V600 mutation: a systematic review and meta-analysis
by: Siin Kim, et al.
Published: (2018-04-01)

Chemotherapy-induced amenorrhea in patients suffering from breast cancer in the Northwest of Iran
by: Jamal Eivazi-Ziaei, et al.
Published: (2014-01-01)

Inherited genetic variants associated with melanoma BRAF/NRAS subtypes
by: Thomas, NE, et al.
Published: (2018)

NRAS and BRAF mutation frequency in primary oral mucosal melanoma
by: Buery, R.R., et al.
Published: (2011)

Seriniquinones as Therapeutic Leads for Treatment of BRAF and NRAS Mutant Melanomas
by: Amanda S. Hirata, et al.
Published: (2021-12-01)